Syra Health Corp. reported a second consecutive profitable quarter for the three months ended June 30, 2026, posting net income of $250,242 compared with a net loss of $(63,596) a year earlier as revenue rose 23% to $2.4 million from $1.9 million. Earnings per share improved to $0.02 from a loss of $(0.01), gross margin widened to 44.5% from 38.7%, and EBITDA turned positive at $253,200 from a loss of $(53,760), giving the company its highest quarterly gross margin on record. For the first six months of 2026, net income was $491,221 versus a net loss of $(535,861) in the prior-year period, while net cash provided by operating activities increased to $643,183 from $85,754. Syra Health said growth was led by its higher-margin population health solutions and an 87% increase in healthcare workforce revenue. The company reiterated its target of full-year profitability for 2026, while cautioning that revenue recognition, contract timing and milestone schedules may continue to cause quarterly variability. Recent developments included contract extensions with Wake County Public Health and the Indiana Veterans' Home, an Indiana FSSA DDRS amendment running through October 2028, formation of a Business Advisory Council, and expected near-term approval of the CMS ACCESS Model partnership with HealthSync. Syra Health ended June with about $2.1 million in cash and no long-term debt.